Arseus Third-Quarter Sales Rise 23%; Company Confirms Forecasts

Oct. 10 (Bloomberg) -- Arseus NV, Europe’s largest supplier of ingredients to compounding pharmacies, said third-quarter sales rose 23 percent to 116.7 million euros.

The company confirmed its sales and profitability forecasts for the full year.

Link to Statement:{NSN LSU4MQ3PR6RK <GO>}

Link to Company News:{RCUS BB <Equity> CN <GO>}

To contact the editor responsible for this story: Andrew Clapham at aclapham@bloomberg.net